Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
World
Nicola Davis Science correspondent

First trial of antiviral monkeypox drug that could speed recovery begins in UK

A patient in the US holds a bottle of Tecovirimat, which is already being used for monkeypox treatment
A patient in the US holds a bottle of Tecovirimat. Photograph: Yuki Iwamura/AFP/Getty Images

The first clinical trial in patients with monkeypox of an antiviral drug that could speed their recovery has begun in the UK.

The trial, known as Platinum, will explore whether Tecovirimat – a drug originally developed for smallpox – may reduce the length of time it takes for skin lesions and ulcers to heal.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.